NCT03962543 2026-04-08ReNeuSpringWorks Therapeutics, Inc.Phase 2 Active not recruiting114 enrolled 25 charts 3 FDA
NCT00924196 2026-03-20Natural History Study of Patients With Neurofibromatosis Type INational Institutes of Health Clinical Center (CC)Active not recruiting259 enrolled
NCT05891847 2025-06-10Non-interventional Study of Patients With PN NF1 Starting Selumetinib in RussiaAstraZenecaActive not recruiting150 enrolled
NCT03820778 2021-03-02Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1Children's National Research InstitutePhase NA Active not recruiting10 enrolled